- Home
- OVID vs SER Comparison
OVID vs SER Comparison
Compare OVID & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- SER
- Stock Information
- Founded
- OVID 2014
- SER 2017
- Country
- OVID United States
- SER United States
- Employees
- OVID N/A
- SER N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- OVID Health Care
- SER Health Care
- Exchange
- OVID Nasdaq
- SER Nasdaq
- Market Cap
- OVID 54.1M
- SER 45.2M
- IPO Year
- OVID 2017
- SER 2018
- Fundamental
- Price
- OVID $0.74
- SER $4.81
- Analyst Decision
- OVID Strong Buy
- SER
- Analyst Count
- OVID 5
- SER 0
- Target Price
- OVID $4.04
- SER N/A
- AVG Volume (30 Days)
- OVID 384.9K
- SER 31.9K
- Earning Date
- OVID 03-07-2025
- SER 11-12-2024
- Dividend Yield
- OVID N/A
- SER N/A
- EPS Growth
- OVID N/A
- SER N/A
- EPS
- OVID N/A
- SER N/A
- Revenue
- OVID $631,695.00
- SER $3,157,500.00
- Revenue This Year
- OVID $71.38
- SER N/A
- Revenue Next Year
- OVID $5,144.81
- SER N/A
- P/E Ratio
- OVID N/A
- SER N/A
- Revenue Growth
- OVID 113.21
- SER 2454.55
- 52 Week Low
- OVID $0.68
- SER $3.81
- 52 Week High
- OVID $4.10
- SER $19.93
- Technical
- Relative Strength Index (RSI)
- OVID 25.31
- SER 46.26
- Support Level
- OVID $0.75
- SER $4.70
- Resistance Level
- OVID $1.01
- SER $5.40
- Average True Range (ATR)
- OVID 0.07
- SER 0.49
- MACD
- OVID -0.02
- SER -0.01
- Stochastic Oscillator
- OVID 6.25
- SER 11.93
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.